Jin Long Chen
Director/Board Member at TENAYA THERAPEUTICS, INC.
Net worth: 2 M $ as of 2024-04-29
Jin Long Chen active positions
| Companies | Position | Start | End |
|---|---|---|---|
| TENAYA THERAPEUTICS, INC. | Director/Board Member | 2016-09-30 | - |
| Independent Dir/Board Member | 2016-09-30 | - |
Career history of Jin Long Chen
Former positions of Jin Long Chen
| Companies | Position | Start | End |
|---|---|---|---|
| NGM BIOPHARMACEUTICALS, INC. | Director/Board Member | 2007-12-31 | 2023-04-03 |
| Chief Tech/Sci/R&D Officer | 2007-12-31 | 2023-04-03 | |
| Founder | 2007-12-19 | 2023-04-03 | |
| President | 2007-12-31 | 2014-10-31 | |
| AMGEN INC. | Chief Tech/Sci/R&D Officer | 2003-12-31 | 2007-12-31 |
| Corporate Officer/Principal | - | 2007-12-31 | |
Tularik, Inc.
 Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - | - |
Training of Jin Long Chen
| Fu Jen Catholic University | Undergraduate Degree |
| National Taiwan University | Graduate Degree |
| University of California, Berkeley | Doctorate Degree |
Statistics
International
| United States | 6 |
| Taiwan | 3 |
Operational
| Director/Board Member | 2 |
| Chief Tech/Sci/R&D Officer | 2 |
| Founder | 2 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 4 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 3 |
|---|---|
| NGM BIOPHARMACEUTICALS, INC. | Health Technology |
| AMGEN INC. | Health Technology |
| TENAYA THERAPEUTICS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Tularik, Inc.
Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | Commercial Services |
- Stock Market
- Insiders
- Jin Long Chen
- Experience
